MDS Highlights From ASCO 2021 MDS Highlights From ASCO 2021

Dr Amy DeZern, of Johns Hopkins University School of Medicine, reviews key studies on myelodysplastic syndromes presented at ASCO 2021, including phase 2 data on enasidenib in higher-risk MDS patients.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news